Study of a herbal compound for COPD in China
Part of Lungs & breathing clinical trials.
This trial tests a traditional Chinese herbal compound formula for people with COPD. It aims to see if the herbal treatment can help improve lung health when used on top of standard inhaler therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 80 years old.
- You have been diagnosed with COPD (chronic obstructive pulmonary disease).
- You have not had a sudden worsening of your COPD symptoms in the last 4 weeks.
- You are not currently on long-term immunosuppressants or systemic steroids.
- You are not pregnant or breastfeeding and are able to use a wearable device.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how traditional Chinese medicine can help people aged 60 and older who have COPD. It aims to see if this approach can improve breathing and quality of life.
This study looks at different forms of COPD to find better ways to treat them. It may help you understand your own condition and receive more personalized care.
This study observes how Chinese medicine affects people with COPD or PRISm (a type of lung impairment). By joining, researchers will track your health over time to find better ways to treat breathing problems.
This study follows people with COPD (chronic lung disease) over many years to better understand the condition. It may help doctors learn what factors predict worsening over time.
This trial tests a traditional Chinese herbal formula for treating sudden worsening of COPD symptoms (called acute exacerbations). It may help reduce inflammation and improve breathing during a flare-up for hospitalized patients.
This study looks at signs (biomarkers) and different types of COPD in Chinese people. It aims to better understand COPD and pre-COPD, which may help with future treatments.
Hear when a new Chronic Obstructive Pulmonary Disease (COPD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.